The involvement of DTX2 in cancer has been initially suggested from the isolation of the cancer-promoting fusion gene product RUNX1-DTX2, as a result of the t (7;21) (q11.2;q22) chromosomal translocation in a set of acute myeloid leukemia patients’ cells [40]. This evidence concerns the gene DTX2 and acute myeloid leukemia.